Live from the NIH registry
Studies recruiting near Joliet right now
Top 25 of 515 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Advocate Children's Hospital-Oak Lawn — Oak Lawn, Illinois (24.2 mi)
· Sponsor: National Cancer Institute (NCI)
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,490 participants sought
Research Site — Hinsdale, Illinois (22.4 mi)
· Sponsor: AstraZeneca
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
HER2-positive Metastatic Breast Cancer
N/A
Observational 200 participants sought
University of Chicago Comprehensive Cancer Center at Silver Cross — New Lenox, Illinois (9.5 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
Nicotinamide Adenine Dinucleotide Responses to a Nutritional Supplement
Healthy Adult
N/A
Interventional 34 participants sought
Biofortis Clinical Research — Addison, Illinois (29.7 mi)
· Sponsor: Shaklee Corporation
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
N/A
Observational 3,000 participants sought
Loyola University Health System — Maywood, Illinois (29.5 mi)
· Sponsor: Duke University
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
UC Comprehensive Cancer Center at Silver Cross — New Lenox, Illinois (9.5 mi)
· Sponsor: SWOG Cancer Research Network
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
University Retina and Macula Associates, PC — Lemont, Illinois (13.2 mi)
· Sponsor: Genentech, Inc.
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10025, Naperville, IL — Naperville, Illinois (18.5 mi)
· Sponsor: Colorado Prevention Center
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Edward Hospital/Cancer Center?Plainfield — Plainfield, Illinois (8.0 mi)
· Sponsor: NRG Oncology
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Intracerebral Hemorrhage
Phase 3
Interventional 350 participants sought
Central DuPage Hospital — Winfield, Illinois (23.7 mi)
· Sponsor: Joseph Broderick, MD
Transition Care for FEP
Schizoaffective Disorders, Bipolar Disorder With Psychotic Features
N/A
Observational 75 participants sought
University of Chicago Ingalls Memorial Hospital — Harvey, Illinois (26.8 mi)
· Sponsor: University of Chicago
Registry Study for Radiation Therapy Outcomes
Neoplasms
N/A
Observational 50,000 participants sought
Northwestern Medicine Chicago Proton Center — Warrenville, Illinois (20.7 mi)
· Sponsor: Proton Collaborative Group
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
Associated Urological Specialists - Chicago Ridge — Chicago Ridge, Illinois (22.9 mi)
· Sponsor: Pfizer
Effects of Effera Human Lactoferrin at One Dose Compared to Placebo on Gut Permeability
Gut Permeability, Gut Health
N/A
Interventional 46 participants sought
Biofortis Inc — Addison, Illinois (29.7 mi)
· Sponsor: Helaina Inc.
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Loyola Medicine Homer Glen — Homer Glen, Illinois (12.3 mi)
· Sponsor: SWOG Cancer Research Network
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Phase 3
Interventional 428 participants sought
Northwestern Medicine Cancer Center Warrenville — Warrenville, Illinois (20.7 mi)
· Sponsor: NRG Oncology
Musculoskeletal and Pelvic Floor Health in Female Chronic Overlapping Pelvic Pain Conditions
Chronic Pelvic Pain Syndrome
N/A
Observational 208 participants sought
Loyola Medical Center — Maywood, Illinois (29.5 mi)
· Sponsor: Loyola University
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
Alzheimer Disease
Phase 4
Interventional 150 participants sought
Essential Concepts Research Solutions (ECRS) — Palos Hills, Illinois (21.1 mi)
· Sponsor: Alpha Cognition, Inc
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Geographic Atrophy, Macular Degeneration
Phase 2
Interventional 274 participants sought
University Retina — Lemont, Illinois (13.2 mi)
· Sponsor: Janssen Research & Development, LLC
Postprandial Response to Fruit Juice
Blood Glucose, Blood Insulin
N/A
Interventional 18 participants sought
Biofortis Innovation Services — Addison, Illinois (29.7 mi)
· Sponsor: Ocean Spray Cranberries, Inc.
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,524 participants sought
Northwestern Medicine Cancer Center Warrenville — Warrenville, Illinois (20.7 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Optimization of NIBS for Treatment of Addiction
Opioid-use Disorder, Chronic Pain
N/A
Interventional 126 participants sought
University of Illinois Health/ University of Illinois at Chicago — Hinsdale, Illinois (22.4 mi)
· Sponsor: Case Western Reserve University
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
Aortic Valve Insufficiency, Aortic Valve Stenosis
N/A
Interventional 200 participants sought
Alexian Brothers Hospital Network — Lisle, Illinois (19.9 mi)
· Sponsor: Edwards Lifesciences
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
Breast Cancer, Breast Neoplasm
Phase 2
Interventional 132 participants sought
Northwestern Medicine Chicago Proton Center — Warrenville, Illinois (20.7 mi)
· Sponsor: Proton Collaborative Group
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Northwestern Medicine Orland Park — Orland Park, Illinois (17.1 mi)
· Sponsor: National Cancer Institute (NCI)